September is World Alzheimer’s month.
Let’s spread awareness together!
Alzheimer’s Disease (AD) is the most wide-spread form of dementia affecting dozens of millions patients worldwide. This is a condition which impacts both the quality of life of the suffering individual and their friends and family. While no cure is currently available, there is a growing number of facilities and treatment options to mitigate the disease and to offer the much-needed support to families. Clinical trials are also ongoing worldwide in search for the cure for Alzheimer’s Disease.
GCT focuses on CNS and Neurology trials and has been running trials in Alzheimer’s Disease since 2001. We are closely familiar with Key Opinion Leaders (KOLs) and the best clinical sites worldwide. Reach out to GCT at email@example.com for more information.
Updated: September 28, 2021
Permanent link: https://2022.gctrials.com/posts/worldalzheimersmonth/